News

Article

Study investigates neurological impact of diabetic vitreous hemorrhage

Author(s):

Key Takeaways

  • Diabetic vitreous hemorrhage is linked to neuropathologic changes in specific brain regions, as identified by voxel-based morphometry.
  • Reduced morphometry values in certain brain areas correlate with hemorrhage duration and anxiety and depression scores.
SHOW MORE

Researchers reported identifying changes in 4 areas of the brain

(Image Credit: AdobeStock/Chinnapong)

(Image Credit: AdobeStock/Chinnapong)

Chinese researchers reported identifying changes in 4 areas of the brains of patients with diabetic vitreous hemorrhage,1 coauthors Li-Jun Ji and Jin-Yu Hu, reported. They are, respectively, from the Department of Ophthalmology, Dahua Hospital, Shanghai, China; and the Department of Endocrine and Metabolic, the First Affiliated Hospital of Nanchang University, Jiangxi Clinical Research Centre for Endocrine and Metabolic Disease, Jiangxi Branch of National Clinical Research Center for Metabolic Disease, and the Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, both in Nanchang, China.

The investigators explained that “prolonged retention of accumulated blood poses the risk of intricate complications including tractional retinal detachment, proliferative retinopathy, cataracts, glaucoma, vitreous atrophy, and other maladies, ultimately leading to irreversible vision impairment.” They cited a study that reported that those consequences exert substantial effects on patients’ lives, economy, and education2 and heightens their susceptibility to mortality.3

Study design

They undertook a study of 21 patients with diabetic vitreous hemorrhage (mean age, 52.29 years) and 21 matched controls with diabetes mellitus. They performed voxel-based morphometry to identify aberrant functional regions in the brain.

They found that compared with the controls, the patients had “reduced voxel-based morphometry values in the right superior temporal pole, the right superior temporal gyrus, the right medial orbital frontal gyrus, and the left superior frontal gyrus.” The voxel-based morphometry segmented and evaluated all of the structures in the brain.

The average values in each region of the brain were correlated negatively with the duration of the diabetic vitreous hemorrhage and the patients’ scores on the Hospital Anxiety and Depression Scale.

These findings led the authors to conclude that diabetic vitreous hemorrhages potentially reflect neuropathologic changes associated with this condition.

References
  1. Ji L-J, Hu J-Y, Yan-Mei Zeng, Y-M, et al. Brain activity in different brain areas of patients with diabetic vitreous hemorrhage according to voxel-based morphometry. Int J Ophthalmol. 2025:258-267. Doi:10.18240/ijo.2025.02.09
  2. Ren JH, Zhang SX, Pan YF, et al. Diabetic retinopathy: Involved cells, biomarkers, and treatments. Front Pharmacol. 2022;13:953691.
  3. Semeraro F, Morescalchi F, Cancarini A, et al. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications. Diabetes Metab. 2019;45:517-527.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.